Connor, Clark & Lunn Investment Management Ltd. Agios Pharmaceuticals, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 22,273 shares of AGIO stock, worth $1.24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

22,273

Previous 37,281 40.26%

Holding current value

$1.24 Million

Previous $1.61 Million 38.46%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$41.19 - $49.72 $618,179 - $746,197	-15,008 Reduced 40.26%	22,273 $989,000
Q2 2024 Aug 09, 2024	BUY	$27.55 - $48.83 $1.03 Million - $1.82 Million	37,281 New	37,281 $1.61 Million
Q4 2023 Feb 09, 2024	BUY	$19.97 - $24.53 $202,316 - $248,513	10,131 New	10,131 $225,000
Q2 2023 Aug 10, 2023	SELL	$21.38 - $29.19 $907,602 - $1.24 Million	-42,451 Reduced 34.64%	80,083 $2.27 Million
Q1 2023 May 09, 2023	SELL	$21.74 - $30.93 $643,677 - $915,775	-29,608 Reduced 19.46%	122,534 $2.81 Million
Q4 2022 Feb 10, 2023	SELL	$24.81 - $31.52 $1.03 Million - $1.3 Million	-41,333 Reduced 21.36%	152,142 $4.27 Million
Q3 2022 Nov 10, 2022	BUY	$19.51 - $34.14 $1.01 Million - $1.77 Million	51,820 Added 36.58%	193,475 $5.47 Million
Q2 2022 Aug 05, 2022	BUY	$17.06 - $31.42 $559,005 - $1.03 Million	32,767 Added 30.09%	141,655 $3.14 Million
Q1 2022 May 12, 2022	BUY	$26.68 - $34.81 $624,578 - $814,902	23,410 Added 27.39%	108,888 $3.17 Million
Q4 2021 Feb 10, 2022	SELL	$29.58 - $49.78 $551,519 - $928,148	-18,645 Reduced 17.91%	85,478 $2.81 Million
Q3 2021 Nov 12, 2021	BUY	$41.92 - $58.18 $3.27 Million - $4.53 Million	77,943 Added 297.72%	104,123 $4.81 Million
Q2 2021 Aug 12, 2021	BUY	$52.06 - $61.27 $917,088 - $1.08 Million	17,616 Added 205.7%	26,180 $1.44 Million
Q1 2021 May 13, 2021	BUY	$44.23 - $57.5 $378,785 - $492,430	8,564 New	8,564 $442,000

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Agios Pharmaceuticals, Inc. Transaction History